Streetbeat News

Revenues

LCID

Lucid Group shares are trading higher following an upgrade to Neutral by Cantor Fitzgerald. The company reported better-than-expected Q2 sales and secured a $1.5 billion commitment from the Public Investment Fund.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 6:36 pm

NUE

Nucor (NYSE:NUE) has outperformed the market over the past 20 years with an average annual return of 10.29%. A $100 investment in NUE 20 years ago would be worth $714.67 today. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:32 pm

TMUS

T-Mobile US (NASDAQ:TMUS) has outperformed the market over the past 5 years, delivering an average annual return of 20.0%. A $1000 investment in TMUS 5 years ago would be worth $2,509.88 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:32 pm

CBS

Former President Trump announced that CBS will host the Vice Presidential debates. This news could impact CBS's stock as it may increase viewership and advertising revenue.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 6:26 pm

DCBO

Docebo shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 6:24 pm

PBR

Brazil's Petrobras has obtained licenses to increase oil production in two fields, according to Reuters citing sources.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 6:09 pm

WBD

Warner Bros. Discovery Inc (NASDAQ:WBD) is shifting its focus towards free-to-play gaming models after a significant decline in gaming revenue, largely due to the poor performance of Suicide Squad: Kill the Justice League. The company aims to leverage its iconic intellectual properties and explore partnerships to enhance its gaming portfolio.

Portfolio Pulse from Franca Quarneti

August 08, 2024 | 6:02 pm

PTVE

Pactiv Evergreen (NASDAQ:PTVE) has received mixed analyst ratings over the past three months, with a recent trend of lowered price targets. Analysts have provided a range of 12-month price targets, with an average of $14.0, down from a previous average of $16.20. The company faces challenges in revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:01 pm

MCO

Moody's (NYSE:MCO) has significantly outperformed the market over the past 15 years, delivering an average annual return of 21.54%. A $100 investment in MCO 15 years ago would be worth $1,840.36 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:00 pm

GH

Guardant Health (NASDAQ:GH) has received a range of analyst ratings over the past three months, with a majority being bullish. Analysts have raised their 12-month price targets, reflecting an average target of $39.67, up from $35.43. The company has shown strong revenue growth but faces challenges with profitability and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:00 pm